Skip to content

Fluid Infusion During Breast Surgery

Phase 4 Study of Fluid Infusion During Breast Surgery.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00431743
Enrollment
32
Registered
2007-02-06
Start date
2009-04-30
Completion date
2009-09-30
Last updated
2009-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Surgery

Keywords

Fluid Therapy, Crystalloid, Colloid, Perioperative, Optimization, Goal-directed Therapy

Brief summary

The investigators want to investigate the effects of two different kinds of fluid infusions given during varicose vein surgery. Both types of fluid are regularly given during surgery, and the investigators want to compare their respective effects on balance, nausea/vomiting and orthostatic function after surgery. The investigators' hypothesis is that using a colloid solution will improve orthostatic function, balance, nausea/vomiting and reduce hospital stay.

Detailed description

The optimal amount and type of fluid given during surgery has not been defined. It has been agreed that hypovolemia must be avoided, but at the same time it has been agreed that fluid excess is harmful for organ function.When distributing fluids it is usually either crystalloids og colloids which are given. The effects of the two types of fluid have not been compared. Our hypothesis is that using a colloid (HES 130/0,4) will improve orthostatic function, nausea/vomiting and shorten hospital stay, compared to using a crystalloid (Lactated Ringer's solution).The amount of fluid the patient receives, will be individually tailored by monitoring SV using esophageal Doppler technique during surgery.

Interventions

DRUGHydroxyethylstarch 130/0,4

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients having performed elective breast surgery. * Age between 18 and 70 years * Patients who have given written consent to participate in the project after haven completely understood the contents and limitations of the protocol.

Exclusion criteria

* Patients who do not understand or speak Danish * Patients who have not signed the informed consent or the written authority * pre-medication, except 1g paracetamol * ASA \> II * Pregnant or breastfeeding * Known to have Renal disease * Known to have Psychiatric disorder (not considering the use of SSRI antidepressive) * Need for crash induction or prone position. * Oesophageal varicoses * Necrosis or cancer in: Mouth, Pharynx, Larynx or Oesophagus * Coarctation or aneurism in the proximal Aorta * Severe bleeding disease

Design outcomes

Primary

MeasureTime frame
To investigate orthostatic function, measured by Finapress

Secondary

MeasureTime frame
To investigate the occurrence of postsurgery nausea/vomiting.
To investigate the amount of time until discharge criteria from the Postanaesthetic Care Unit have been achieved.
To investigate balance function, measured by BalanceMaster

Countries

Denmark

Contacts

Primary ContactMorten Bundgaard-Nielsen, M.D.
morten.bundgaard-nielsen@rh.hosp.dk0045 35452674
Backup ContactHenrik Kehlet, M.D. Ph.d
henrik.kehlet@rh.hosp.dk0045 35454074

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026